awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q38525073-1F162C3F-F7DE-4851-865F-DD9B09310AFB
Q38525073-1F162C3F-F7DE-4851-865F-DD9B09310AFB
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38525073-1F162C3F-F7DE-4851-865F-DD9B09310AFB
An overview of angiogenesis inhibitors in Phase II studies for non-small-cell lung cancer.
P2860
Q38525073-1F162C3F-F7DE-4851-865F-DD9B09310AFB
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38525073-1F162C3F-F7DE-4851-865F-DD9B09310AFB
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
cecb4aa7dee6a5c9309ad7ff25a16819bcf5a488
P2860
Phase Ib trial of the oral angiogenesis inhibitor pazopanib administered concurrently with pemetrexed in patients with advanced solid tumors.